Fortis Healthcare Ltd.
Snapshot View

291.35 +3.55 ▲1.2%

06 December 2022, 04:07:26 PM
Volume: 1,509,391

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.fortishealthcare.com
Market Cap 22,033.45 Cr.
Enterprise Value(EV) 22,267.36 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.77 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 43.09 Trailing Twelve Months Ending 2022-09
Industry PE 50.25 Trailing Twelve Months Ending 2022-09
Book Value / Share 86.25 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.38 Calculated using Price: 291.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 75.50 Cr. 754,958,148 Shares
FaceValue 10
Company Profile
The company is a leading integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company holds interests in its subsidiaries, associates and joint ventures which manages and operates a network of multi-specialty hospitals and diagnostics centres.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.23%
1 Week
-0.99%
1 Month
+3.17%
3 Month
+1.32%
6 Month
+20.12%
1 Year
+7.47%
2 Year
+104.89%
5 Year
+101.28%
10 Year
+162.48%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -5.74 -3.94 -0.75 -0.15 -21.56 -11.09 1.20 -1.62 12.46
Return on Capital Employed (%) 0.36 -0.12 1.52 4.43 -10.57 -1.89 5.21 2.10 15.28
Return on Assets (%) -2.15 -2.13 -0.42 -0.08 -11.09 -5.94 0.71 -0.95 6.87

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4,952 4,718 4,461 5,143 4,062 6,601 6,661 6,120 6,178 6,948
Non Curr. Liab. 1,787 1,112 704 1,247 876 782 1,170 2,834 3,238 2,812
Curr. Liab. 972 1,602 1,450 1,926 2,134 3,591 2,579 1,233 1,269 1,323
Minority Int. 139 153 392 1,167 1,255 512 545 598 830 840
Equity & Liab. 7,851 7,585 7,007 9,484 8,327 11,486 10,955 10,784 11,516 11,923
Non Curr. Assets 5,810 5,947 5,592 7,709 7,045 9,819 10,014 9,748 10,382 10,739
Curr. Assets 2,040 1,636 1,415 1,775 1,282 1,667 940 1,037 1,133 1,184
Misc. Exp. not W/O 1
Total Assets 7,851 7,585 7,007 9,484 8,327 11,486 10,955 10,784 11,516 11,923

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 3,492 3,966 4,199 4,574 4,561 4,469 4,632 4,030 5,718 5,940
Other Income 167 96 156 166 140 92 53 47 27 49
Total Income 3,659 4,062 4,355 4,740 4,701 4,562 4,685 4,077 5,745 5,989
Total Expenditure -3,440 -3,835 -3,995 -4,221 -4,288 -4,244 -4,023 -3,626 -4,649 -4,878
PBIDT 219 226 360 519 413 318 662 451 1,096 1,111
Interest -250 -152 -133 -229 -258 -337 -205 -166 -147 -132
Depreciation -183 -235 -225 -222 -239 -233 -292 -291 -301 -305
Taxation -11 -5 8 -72 -23 -114 -148 -99 -198 -182
Exceptional Items -5 0 -40 -2 -881 -222 62 1 315 60
PAT -229 -164 -31 -7 -988 -588 79 -104 766 552
Minority Interest -5 -14 -23 -58 -75 -75 -34 -54 -235 -70
Share Associate 11 60 72 486 53 364 12 48 24 29
Other Related Items
Consolidated Net Profit 123 -144 18 422 -1,009 -299 58 -110 555 511
Adjusted EPS -5 -3 0 8 -19 -4 1 -1 7 7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,644 479 24 195 966 493 -179 172 485 865
Cash Fr. Inv. -1,003 2,669 213 113 -1,002 -335 -3,323 60 -135 -514
Cash Fr. Finan. -74 -3,217 -304 -354 259 -672 4,257 -862 -143 -517
Net Change 567 -69 -67 -47 224 -515 755 -630 207 -166
Cash & Cash Eqvt 485 249 183 142 348 -165 634 7 219 67

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 31.17 31.17 31.17 31.17 31.17 31.17 31.17 31.17 31.17
Public 68.83 68.83 68.83 68.83 68.83 68.83 68.83 68.83 68.83
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 25 Nov 2022
Related Party Transaction
Fortis Healthcare Limited has informed the Exchange about related party transaction for the period ended September 30, 2022.
Thu, 24 Nov 2022
Related Party Transaction
Fortis Healthcare Limited has informed the Exchange about related party transaction for the period ended September 30, 2022.
Fri, 18 Nov 2022
Communication to shareholders as per Reg 30
This is in continuation to our letter dated September 22, 2022, September 23, 2022 and November 11, 2022, kindly find attached herewith announcement made by IHH Healthcare Berhad dated November 17, 2022 on Malaysian Stock Exchange (i.e. Bursa Malaysia) with respect to pending Open Offer of the Company and Fortis Malar Hospitals Limited.We will keep the stock exchanges updated / informed regarding material development in this matter.

Technical Scans View Details >>

Mon, 05 Dec 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,386.88 1,035.00 -0.2%
Cipla Ltd. 90,016.94 1,109.60 -0.5%
Divi's Laboratories Ltd. 89,432.38 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. 74,582.06 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. 68,701.75 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. 54,598.02 1,615.60 -0.2%
Abbott India Ltd. 42,923.27 20,207.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.65 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 35.09 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 29.88 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.99 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 81.83 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.50 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 48.68 20,207.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.69 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 4.11 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.59 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.48 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.96 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 15.81 20,207.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 0.00 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,207.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 798.70 20,207.65 +0.7%

FAQ's On Fortis Healthcare Ltd.

What is Fortis Healthcare share price?

Can I buy Fortis Healthcare shares now?

What is the Market Cap of Fortis Healthcare?

What are the key metrics to analyse Fortis Healthcare?

What is the 52 Week High and Low of Fortis Healthcare?

What is the trend of Fortis Healthcare share price?